Analyst Ratings for Akcea Therapeutics, Inc. (AKCA)

AKCA Rating Summary

  |   Expand Research on AKCA
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 2 / 10   Percentile Rank: 39%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
9/1/2020 BMO Capital Do Kim Downgrade Market Perform
(Outperform)		 18.15
(26.00)		 11.38
(18.17)		 59.67% Details
8/31/2020 Wells Fargo Jim Birchenough Downgrade Equal Weight
(Overweight)		 N/A
(N/A)		 11.38
(18.17)		 59.67% Details